Literature DB >> 2536848

Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity.

R H Bonneau1, S R Jennings.   

Abstract

The ability of highly lytic herpes simplex virus (HSV) cytolytic T lymphocytes to modulate the interaction between the murine host (adult C57BL/6 [H-2b] mice) and HSV type 1 Patton resulting in acute infection in the footpad and latent infection in the sensory lumbosacral dorsal root ganglia (L6, L5, L4, and L3) innervating the footpad was investigated. Results indicated that a critical threshold level of infectious HSV was required to establish infection. The adoptive transfer of cytolytic T lymphocytes derived from in vitro cultures after restimulation with HSV-infected, syngeneic stimulator cells exhibiting class I H-2-restricted, L3T4- Lyt-2+ HSV-specific cytolytic activity immediately before infection with a high dose of HSV reduced the levels of infectious HSV recovered from the footpad tissue during acute infection and the levels of latent HSV reactivated from the dorsal root ganglia to levels expected from mice infected with a low dose. Depletion of Lyt-2+ cells from the transferred population abrogated the protective ability, while depletion of L3T4+ cells had little effect. These results suggest that functionally lytic HSV-specific cytolytic T lymphocytes present at the time of HSV infection have the potential to participate in the control of the acute infection and in the subsequent establishment of latent infection.

Entities:  

Mesh:

Year:  1989        PMID: 2536848      PMCID: PMC247856     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.

Authors:  J F Bukowski; R M Welsh
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

2.  Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.

Authors:  K N Leung; A A Nash; D Y Sia; P Wildy
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

3.  Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.

Authors:  K J Cremer; M Mackett; C Wohlenberg; A L Notkins; B Moss
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

4.  Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.

Authors:  B T Rouse; L S Miller; L Turtinen; R N Moore
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

5.  Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice.

Authors:  L F Kastrukoff; A S Lau; M L Puterman
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

6.  Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus.

Authors:  W Chmielarczyk; H Engler; R Ernst; U Opitz; H Kirchner
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

7.  Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci.

Authors:  C Lopez
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

8.  Role of NK cells in protection of mice against herpes simplex virus-1 infection.

Authors:  B Rager-Zisman; P C Quan; M Rosner; J R Moller; B R Bloom
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

9.  Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.

Authors:  S R Jennings; P L Rice; S Pan; B B Knowles; S S Tevethia
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization.

Authors:  W G Stroop; D L Rock; N W Fraser
Journal:  Lab Invest       Date:  1984-07       Impact factor: 5.662

View more
  39 in total

1.  Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.

Authors:  M Erturk; T J Hill; C Shimeld; R Jennings
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.

Authors:  T Hanke; F L Graham; K L Rosenthal; D C Johnson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Authors:  David J Davido; Eleain M Tu; Hong Wang; Maria Korom; Andreu Gazquez Casals; P Jahnu Reddy; Heba H Mostafa; Benjamin Combs; Steve D Haenchen; Lynda A Morrison
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias.

Authors:  S C Cose; J M Kelly; F R Carbone
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.

Authors:  T M Tumpey; H Cheng; D N Cook; O Smithies; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63.

Authors:  Aldo Pourchet; Richard Copin; Matthew C Mulvey; Bo Shopsin; Ian Mohr; Angus C Wilson
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

7.  Protection of mice from herpes simplex virus-induced retinitis by in vitro-activated immune cells.

Authors:  J U Igietseme; P J Calzada; A R Gonzalez; J W Streilein; S S Atherton
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Stress-induced glucocorticoids at the earliest stages of herpes simplex virus-1 infection suppress subsequent antiviral immunity, implicating impaired dendritic cell function.

Authors:  Michael D Elftman; John T Hunzeker; Jennifer C Mellinger; Robert H Bonneau; Christopher C Norbury; Mary E Truckenmiller
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

9.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

10.  Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.

Authors:  Sharvan Sehrawat; Pradeep B J Reddy; Naveen Rajasagi; Amol Suryawanshi; Mitsuomi Hirashima; Barry T Rouse
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.